279 related articles for article (PubMed ID: 18677282)
21. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
22. Correlation of expression of nuclear proteins pKi67 and p63 with lectin histochemical features in head and neck squamous cell cancer.
Chovanec M; Smetana K; Betka J; Plzák J; Brabec J; Moya-Alvarez V; André S; Kodet R; Gabius HJ
Int J Oncol; 2005 Aug; 27(2):409-15. PubMed ID: 16010422
[TBL] [Abstract][Full Text] [Related]
23. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
[TBL] [Abstract][Full Text] [Related]
24. Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers.
Juhász A; Bárdos H; Répássy G; Adány R
Laryngoscope; 2000 Jan; 110(1):84-92. PubMed ID: 10646721
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
26. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
[TBL] [Abstract][Full Text] [Related]
27. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
Honjo Y; Inohara H; Akahani S; Yoshii T; Takenaka Y; Yoshida J; Hattori K; Tomiyama Y; Raz A; Kubo T
Clin Cancer Res; 2000 Dec; 6(12):4635-40. PubMed ID: 11156213
[TBL] [Abstract][Full Text] [Related]
28. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
29. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
Rosenthal EL; Vidrine DM; Zhang W
Laryngoscope; 2006 Jul; 116(7):1086-92. PubMed ID: 16826041
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
31. Validation of tissue array technology in head and neck squamous cell carcinoma.
Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
[TBL] [Abstract][Full Text] [Related]
32. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
[TBL] [Abstract][Full Text] [Related]
33. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast.
Fernandez-Aguilar S; Noël JC
APMIS; 2008 Jan; 116(1):33-40. PubMed ID: 18254778
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome.
Brustmann H
Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315
[TBL] [Abstract][Full Text] [Related]
36. Potential biomarkers for head and neck squamous cell carcinoma.
Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X
Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185
[TBL] [Abstract][Full Text] [Related]
37. The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas.
Li X; Izumaru S; Sakamoto K; Miyajima Y; Nakashima T
J Laryngol Otol; 2006 Dec; 120(12):1042-8. PubMed ID: 16995968
[TBL] [Abstract][Full Text] [Related]
38. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
Shimizu Y; Tsukagoshi H; Fujita M; Hosokawa M; Watanabe A; Kawabori S; Kato M; Sugiyama T; Asaka M
Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of CD1a+ dendritic cells in glottic squamous cell carcinoma].
Chen WK; Chen FJ; Zeng ZY; Wu GH; Guo ZM; Wei MW; Yang AK; Zhang Q; He JH; Hou JH
Ai Zheng; 2005 Sep; 24(9):1124-6. PubMed ID: 16159438
[TBL] [Abstract][Full Text] [Related]
40. Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas.
Saussez S; Decaestecker C; Cludts S; Ernoux P; Chevalier D; Smetana K; André S; Leroy X; Gabius HJ
Anticancer Res; 2009 Jan; 29(1):59-65. PubMed ID: 19331133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]